Filing Details

Accession Number:
0001209191-10-014268
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-03 12:00:00
Reporting Period:
2010-03-01
Filing Date:
2010-03-03
Accepted Time:
2010-03-03 19:30:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339455 Somaxon Pharmaceuticals Inc. SOMX Pharmaceutical Preparations (2834) 200161599
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346901 Jeffrey Raser Somaxon Pharmaceuticals, Inc.
3830 Valley Centre Drive, Suite 705-461
San Diego CA 92130
Senior Vp, Sales And Marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-01 24,110 $1.23 24,110 No 4 M Direct
Common Stock Acquisiton 2010-03-01 19,444 $1.23 43,554 No 4 M Direct
Common Stock Acquisiton 2010-03-01 35,000 $1.23 78,554 No 4 M Direct
Common Stock Acquisiton 2010-03-01 5,446 $1.23 84,000 No 4 M Direct
Common Stock Disposition 2010-03-01 84,000 $4.08 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Disposition 2010-03-01 24,110 $0.00 24,110 $1.23
Common Stock Common Stock Disposition 2010-03-01 19,444 $0.00 19,444 $1.23
Common Stock Common Stock Disposition 2010-03-01 35,000 $0.00 35,000 $1.23
Common Stock Common Stock Disposition 2010-03-01 5,446 $0.00 5,446 $1.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,223 2016-01-05 No 4 M Direct
13,889 2017-03-01 No 4 M Direct
25,000 2018-02-18 No 4 M Direct
77,887 2019-02-16 No 4 M Direct
Footnotes
  1. This sale was effected by the reporting person pursuant to a pre-planned selling program under Rule 10b5-1 adopted by the reporting person in 2009.
  2. 1/3 of the shares of Common Stock subject to this grant vested on the date of grant (June 9, 2009) and the remaining shares will vest and become exercisable in 24 equal monthly installments over the following two year period.
  3. Not applicable.